Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Jun 12, 2026
Data as of Oct 16
▼ SELL$229K3,260 shares at $70.34Arjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.
- Traded
- Jun 12, 2026
- Disclosed
- Jun 15, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ORKA since disclosure
+4.5%
after the sale
Similar stocks (XLV) since disclosure
+15.6%
XLV — its sector index fund
Change in closing price from Jun 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$27.5Kdisclosed Jun 15 · filed the same day
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$127Kdisclosed Jun 15 · filed 3 days after the trade
- ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$303Kdisclosed Jun 15 · filed 3 days after the trade